Individual, Social, and Environmental Factors Associated with Different Patterns of Stimulant Use: A Cross-Sectional Study from Five European Countries.


Journal

European addiction research
ISSN: 1421-9891
Titre abrégé: Eur Addict Res
Pays: Switzerland
ID NLM: 9502920

Informations de publication

Date de publication:
2023
Historique:
received: 08 09 2022
accepted: 24 02 2023
medline: 23 10 2023
pubmed: 11 5 2023
entrez: 11 5 2023
Statut: ppublish

Résumé

Amphetamine-type stimulants (ATSs) are the second most commonly consumed class of illicit drugs globally, but there is limited understanding of the precise factors associated with problematic versus controlled ATS consumption. This exploratory study aimed to identify which individual, social, and environmental factors are associated with different patterns of ATS use over time. Cross-sectional surveys were conducted in Germany, England, The Netherlands, Poland, and the Czech Republic via face-to-face computer-assisted personal interviews to collect data on different user groups. 1,458 adults (18+) reported exposure to but no ATS use (n = 339); former rare/moderate ATS use (n = 242); current rare/moderate ATS use (n = 273); former frequent/dependent ATS use (n = 201); current frequent/dependent ATS use (n = 403). Extent of ATS/other substance use was assessed by number of consumption days (lifetime, past year, past month) and Severity of Dependence Scale. To identify factors associated with group membership, data were also collected on previous injecting drug use (IDU) and consumption setting/rules. Psychological distress was measured using the Brief Symptom Inventory, with additional data collected on self-reported adverse life events and physical/mental health. Currently, using frequent/dependent ATS users experienced more frequent unstable living conditions (27.5%) and psychological distress (59.8%) compared to other groups. A multinomial logistic regression showed that currently abstinent rare/moderate users were more likely to abstain from methamphetamine use {odds ratio (OR) = 2.48 (confidence interval [CI] = 1.32-4.68)} and from IDU (OR = 6.33 [CI = 2.21-18.14]), to avoid ATS use during working hours (OR = 6.67 [CI = 3.85-11.11]), and not to use ATS for coping reasons (OR = 4.55 [CI = 2.50-6.67]) compared to the reference group of currently using frequent/dependent users. People who use ATS frequently and/or at dependent levels are more likely to have experienced social and economic adversity compared to infrequent ATS users. On the other hand, there is a substantial share of users, which show a controlled use pattern and are able to integrate ATS use into their lives without severe consequences.

Identifiants

pubmed: 37166303
pii: 000529944
doi: 10.1159/000529944
doi:

Substances chimiques

Central Nervous System Stimulants 0
Amphetamine CK833KGX7E
Methamphetamine 44RAL3456C

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

182-193

Informations de copyright

© 2023 S. Karger AG, Basel.

Auteurs

Moritz Rosenkranz (M)

Department of Psychiatry, Centre for Interdisciplinary Addiction Research of Hamburg University (ZIS), University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Amy O'Donnell (A)

Population Health Sciences Institute, Faculty of Medical Science, Newcastle University, Newcastle, UK.

Marcus-Sebastian Martens (MS)

Department of Psychiatry, Centre for Interdisciplinary Addiction Research of Hamburg University (ZIS), University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Heike Zurhold (H)

Department of Psychiatry, Centre for Interdisciplinary Addiction Research of Hamburg University (ZIS), University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Peter Degkwitz (P)

Department of Psychiatry, Centre for Interdisciplinary Addiction Research of Hamburg University (ZIS), University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Nienke Liebregts (N)

Research and Documentation Centre (WODC), Ministry of Justice and Security, The Hague, The Netherlands.

Miroslav Barták (M)

Department of Addictology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia.

Magdalena Rowicka (M)

Academy of Special Education, Institute of Applied Psychology, Maria Grzegorzewska University, Warsaw, Poland.

Uwe Verthein (U)

Department of Psychiatry, Centre for Interdisciplinary Addiction Research of Hamburg University (ZIS), University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH